AliMOderuthEAtchiaIMalviyaA.The use of platelet-rich plasma in the treatment of greater trochanteric pain syndrome: a systematic literature review. J Hip Preserv Surg. 2018;5(3):209-219.
ArthursJRNordanLMHultgrenBHetal. Patients seeking stem cell therapies—a prospective qualitative analysis from a regenerative medicine consult service. NPJ Regen Med. 2022;7(1):20.
5.
BelkJWKraeutlerMJHouckDAGoodrichJADragooJLMcCartyEC.Platelet-rich plasma versus hyaluronic acid for knee osteoarthritis: a systematic review and meta-analysis of randomized controlled trials. Am J Sports Med. 2021;49(1):249-260.
6.
BendichIRubensteinWJColeBJMaCBFeeleyBTLansdownDA.What is the appropriate price for platelet-rich plasma injections for knee osteoarthritis? A cost-effectiveness analysis based on evidence from level I randomized controlled trials. Arthroscopy. 2020;36(7):1983-1991.e1981.
7.
BlomAWDonovanRLBeswickADWhitehouseMRKunutsorSK.Common elective orthopaedic procedures and their clinical effectiveness: umbrella review of level 1 evidence. BMJ. 2021;374:n1511.
8.
BufordDTulpuleSHyderJBootH.The average level of evidence of papers published in six orthopedic journals. Biol Orthop J. 2020;2(1):e48-e50.
9.
ChuCRRodeoSBhutaniNetal. Optimizing clinical use of biologics in orthopaedic surgery: consensus recommendations from the 2018 AAOS/NIH U-13 conference. J Am Acad Orthop Surg. 2019;27(2):e50-e63.
10.
EliasbergCDNemirovDAMandelbaumBRetal. Complications following biologic therapeutic injections: a multicenter case series. Arthroscopy. 2021;37(8):2600-2605.
11.
EvertsPOnishiKJayaramPLanaJFMautnerK.Platelet-rich plasma: new performance understandings and therapeutic considerations in 2020. Int J Mol Sci. 2020;21(20):7794.
12.
FinnoffJTHallMMAdamsEet al. American Medical Society for Sports Medicine (AMSSM) position statement: interventional musculoskeletal ultrasound in sports medicine. PMR. 2015 Feb;7(2):151-68.e12.
13.
FinnoffJTAwanTMBorg-SteinJet al.American Medical Society for Sports Medicine position statement: principles for the responsible use of regenerative medicine in sports medicine. Clin J Sport Med. 2021;31(6):530-541.
14.
FitzpatrickJBulsaraMZhengMH.The effectiveness of platelet-rich plasma in the treatment of tendinopathy: a meta-analysis of randomized controlled clinical trials. Am J Sports Med. 2017;45(1):226-233.
15.
FosterTE.Direct-to-consumer marketing: the ethics of snake oil sales?Am J Sports Med. 2023;51(5):1133-1135.
16.
HawkeBPrzybyloARPaciulliDCaulfieldTZarzecznyAMasterZ.How to peddle hope: an analysis of YouTube patient testimonials of unproven stem cell treatments. Stem Cell Reports. 2019;12(6):1186-1189.
17.
HollandCJaegerLSmentkowskiUWeberBOttoC.Septic and aseptic complications of corticosteroid injections: an assessment of 278 cases reviewed by expert commissions and mediation boards from 2005 to 2009. Dtsch Arztebl Int.2012;109(24):425-430.
18.
HongMChengCSunXetal. Efficacy and safety of intra-articular platelet-rich plasma in osteoarthritis knee: a systematic review and meta-analysis. Biomed Res Int. 2021;2021:2191926.
19.
KamenovaKReshefACaulfieldT.Representations of stem cell clinics on Twitter. Stem Cell Rev Rep.2014;10(6):753-760.
20.
KingeryMTSchoofLStraussEJBoscoJAHalbrechtJ.Online direct-to-consumer advertising of stem cell therapy for musculoskeletal injury and disease: misinformation and violation of ethical and legal advertising parameters. J Bone Joint Surg Am. 2020;102(1):2-9.
21.
ManchikantiLCentenoCJAtluriSetal. Bone marrow concentrate (BMC) therapy in musculoskeletal disorders: evidence-based policy position statement of American Society of Interventional Pain Physicians (ASIPP). Pain Physician. 2020;23(2):E85-E131.
22.
MarconARMurdochBCaulfieldT.Fake news portrayals of stem cells and stem cell research. Regen Med.2017;12(7):765-775.
23.
MomayaAMMcGeeASDombrowskyARWildAJFaroquiNMWaldropRP.The cost variability of orthobiologics. Sports Health. 2020;12(1):94-98.
24.
NiemiecPSzylukKJaroszAIwanickiTBalcerzykA.Effectiveness of platelet-rich plasma for lateral epicondylitis: a systematic review and meta-analysis based on achievement of minimal clinically important difference. Orthop J Sports Med. 2022;10(4):232596 71221086920.
25.
NobackPCDonnelleyCAYeattsNCetal. Utilization of orthobiologics by sports medicine physicians: a survey-based study. J Am Acad Orthop Surg Glob Res Rev. 2021;5(1):e20.00185.
26.
RodeoSABediA.2019-2020 NFL and NFL physician society orthobiologics consensus statement. Sports Health. 2020;12(1):58-60.
27.
SakaleHSAgrawalACNayakBKarBDashRNYadavSK.Adverse event following platelet rich plasma injection for the management of early osteoarthritis of knee—a report of 4 cases. Int J Orthop Rheumatol. 2021;7(1):42-45.
28.
SakaleHSAgrawalACNayakBKarBKSharmaSBhardwajS.Evaluation of outcome of intraarticular PRP injection in osteoarthritis knee. J Arthritis. 2021;10(10):001-003.
29.
SánchezMJorqueraCSánchezPetal. Platelet-rich plasma injections delay the need for knee arthroplasty: a retrospective study and survival analysis. Int Orthop. 2021;45(2):401-410.
30.
ShapiroSAFinnoffJTAwanTMetal. Highlights from the American Medical Society for Sports Medicine position statement on responsible use of regenerative medicine and orthobiologics in sports medicine. Br J Sports Med. 2022;56(3):121-122.
31.
ShapiroSAMasterZArthursJRMautnerK.Tiered approach to considering orthobiologics for patients with musculoskeletal conditions. Br J Sports Med. 2023;57(3):179-180.
32.
SungKZhengKWilliamsCCunninghamDSussmanWI.Pseudoseptic reaction to an intra-articular platelet-rich plasma injection into the knee: a case report. Regen Med. 2023;18(6):455-459.
33.
TurnerL.The American stem cell sell in 2021: U.S. businesses selling unlicensed and unproven stem cell interventions. Cell Stem Cell.2021;28(11):1891-1895.
34.
TurnerLKnoepflerP.Selling stem cells in the USA: assessing the direct-to-consumer industry. Cell Stem Cell. 2016;19(2):154-157.
